- Filed
- Jul 31, 2020 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 19, 2020 | 71.66M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $5.07K |
| Capex | Q1 2020 · Mar 31, 2019 | $1.55K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$231.39K |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | −$378.13K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $14.87K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $69.33K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2019 | $15.36K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2018 | $25.04K |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | −$29.33M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | −$28.4M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $30.16M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $29.44M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $30.28M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $29.59M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $823.71K |
| Current Assets | Q1 2020 · Dec 31, 2019 | $1.04M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $951.02K |
| Total Assets | Q1 2020 · Dec 31, 2019 | $1.19M |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $596.07K |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $425.8K |
| Net Income | Q1 2020 · Mar 31, 2020 | −$928.35K |
| Net Income | Q1 2020 · Dec 31, 2019 | −$1.17M |
| Net Income | Q1 2020 · Sep 30, 2019 | −$747.8K |
| Net Income | Q1 2020 · Jun 30, 2019 | −$614.99K |
| Net Income | Q1 2020 · Mar 31, 2019 | −$727.76K |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$533.74K |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$399.75K |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $64.91K |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $41.66K |
| Revenue | Q1 2020 · Mar 31, 2020 | $127.55K |
| Revenue | Q1 2020 · Mar 31, 2019 | $67.92K |